These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6139992)

  • 1. Thought disorder. The measurement of its changes.
    Hurt SW; Holzman PS; Davis JM
    Arch Gen Psychiatry; 1983 Dec; 40(12):1281-5. PubMed ID: 6139992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of clinical status of schizophrenic patients by the WAIS comprehension subtest.
    Bigelow LB; Donnelly EP; Torrey EF; Lee CA
    J Clin Psychiatry; 1979 Jun; 40(6):258-61. PubMed ID: 36371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive validity of the Rorschach Prognostic Rating Scale with schizophrenic patients.
    Newmark CS; Konanc JT; Simpson M; Boren RB; Prillaman K
    J Nerv Ment Dis; 1979 Mar; 167(3):135-43. PubMed ID: 438781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment.
    Biagiarelli M; Curto M; Di Pomponio I; Comparelli A; Baldessarini RJ; Ferracuti S
    Psychiatry Res; 2017 May; 251():294-297. PubMed ID: 28236781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Episodic and residual thought pathology in chronic schizophrenics: effect of neuroleptics.
    Spohn HE; Coyne L; Larson J; Mittleman F; Spray J; Hayes K
    Schizophr Bull; 1986; 12(3):394-407. PubMed ID: 2876514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the assessment of thought disorder from the Rorschach.
    Frank G
    Psychol Rep; 1994 Aug; 75(1 Pt 2):375-83. PubMed ID: 7809311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The categorization of thought disorder.
    Berenbaum H; Barch D
    J Psycholinguist Res; 1995 Sep; 24(5):349-76. PubMed ID: 8551455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating bizarre-idiosyncratic thinking: a comprehensive index of positive thought disorder.
    Marengo JT; Harrow M; Lanin-Kettering I; Wilson A
    Schizophr Bull; 1986; 12(3):497-511. PubMed ID: 3764365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring schizophrenic thinking in older adolescents with the WAIS, Rorschach and WIST.
    Bilett JL; Jones NF; Whitaker LC
    J Clin Psychol; 1982 Apr; 38(2):232-43. PubMed ID: 7068856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multimethod approach to assessing perseverations in schizophrenia patients.
    Perry W; Braff DL
    Schizophr Res; 1998 Sep; 33(1-2):69-77. PubMed ID: 9783346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.
    Lewine RR
    Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
    Bilder RM; Goldman RS; Robinson D; Reiter G; Bell L; Bates JA; Pappadopulos E; Willson DF; Alvir JM; Woerner MG; Geisler S; Kane JM; Lieberman JA
    Am J Psychiatry; 2000 Apr; 157(4):549-59. PubMed ID: 10739413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.
    Vothknecht S; Schoevers RA; de Haan L
    Aust N Z J Psychiatry; 2011 Mar; 45(3):182-92. PubMed ID: 21438745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopathology and mental retardation: a study using the Rorschach Inkblot Test.
    Di Nuovo SF; Buono S; Colucci G; Pellicciotta A
    Psychol Rep; 2004 Jun; 94(3 Pt 2):1313-21. PubMed ID: 15362410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients.
    Perry W; Geyer MA; Braff DL
    Arch Gen Psychiatry; 1999 Mar; 56(3):277-81. PubMed ID: 10078506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thought disorder on the WAIS-R relative to the Rorschach: assessing identity-disordered adolescents.
    Skelton MD; Boik RJ; Madero JN
    J Pers Assess; 1995 Dec; 65(3):533-49. PubMed ID: 8609586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of thought disorders. I. Mania and schizophrenia.
    Solovay MR; Shenton ME; Holzman PS
    Arch Gen Psychiatry; 1987 Jan; 44(1):13-20. PubMed ID: 3800579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Information-processing deficits and thought disorder in schizophrenia.
    Perry W; Braff DL
    Am J Psychiatry; 1994 Mar; 151(3):363-7. PubMed ID: 8109644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.